Aspen Pharmacare HL-Unsp ADRAPNHY
13F holders, Q1 2025 (March 31)1holders
0new positions
0sold out
$8.77avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Aspen Pharmacare HL-Unsp ADR (APNHY) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holder was Rhumbline Advisers ($7K).
- Company
- Aspen Pharmacare HL-Unsp ADR
- CUSIP
- 04530Y106
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 225 shares bought, net +225 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Rhumbline Advisers | 0.00% | Add +36.9% | 835 | $7K |
"% of holder's portfolio" is APNHY's weight in each manager's 13F, not the share of Aspen Pharmacare HL-Unsp ADR the manager owns.